These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
835 related items for PubMed ID: 12902418
1. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies. Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA. J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418 [Abstract] [Full Text] [Related]
2. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice. Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA. J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484 [Abstract] [Full Text] [Related]
3. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging. Perk LR, Vosjan MJ, Visser GW, Budde M, Jurek P, Kiefer GE, van Dongen GA. Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566 [Abstract] [Full Text] [Related]
4. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab. Perk LR, Visser GW, Vosjan MJ, Stigter-van Walsum M, Tijink BM, Leemans CR, van Dongen GA. J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605 [Abstract] [Full Text] [Related]
5. Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET. Verel I, Visser GW, Boerman OC, van Eerd JE, Finn R, Boellaard R, Vosjan MJ, Stigter-van Walsum M, Snow GB, van Dongen GA. Cancer Biother Radiopharm; 2003 Aug; 18(4):655-61. PubMed ID: 14503961 [Abstract] [Full Text] [Related]
6. Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice. Meijs WE, Haisma HJ, Klok RP, van Gog FB, Kievit E, Pinedo HM, Herscheid JD. J Nucl Med; 1997 Jan; 38(1):112-8. PubMed ID: 8998164 [Abstract] [Full Text] [Related]
7. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET. Vugts DJ, Klaver C, Sewing C, Poot AJ, Adamzek K, Huegli S, Mari C, Visser GWM, Valverde IE, Gasser G, Mindt TL, van Dongen GAMS. Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793 [Abstract] [Full Text] [Related]
8. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients. Börjesson PK, Jauw YW, de Bree R, Roos JC, Castelijns JA, Leemans CR, van Dongen GA, Boellaard R. J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762 [Abstract] [Full Text] [Related]
9. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA. Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2133-40. PubMed ID: 16609026 [Abstract] [Full Text] [Related]
10. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30. Perk LR, Stigter-van Walsum M, Visser GW, Kloet RW, Vosjan MJ, Leemans CR, Giaccone G, Albano R, Comoglio PM, van Dongen GA. Eur J Nucl Med Mol Imaging; 2008 Oct 01; 35(10):1857-67. PubMed ID: 18491091 [Abstract] [Full Text] [Related]
11. Fully Automated 89Zr Labeling and Purification of Antibodies. Poot AJ, Adamzek KWA, Windhorst AD, Vosjan MJWD, Kropf S, Wester HJ, van Dongen GAMS, Vugts DJ. J Nucl Med; 2019 May 01; 60(5):691-695. PubMed ID: 30530830 [Abstract] [Full Text] [Related]
12. Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography. Perk LR, Visser OJ, Stigter-van Walsum M, Vosjan MJ, Visser GW, Zijlstra JM, Huijgens PC, van Dongen GA. Eur J Nucl Med Mol Imaging; 2006 Nov 01; 33(11):1337-45. PubMed ID: 16832633 [Abstract] [Full Text] [Related]
13. High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy. Verel I, Visser GW, Vosjan MJ, Finn R, Boellaard R, van Dongen GA. Eur J Nucl Med Mol Imaging; 2004 Dec 01; 31(12):1645-52. PubMed ID: 15290121 [Abstract] [Full Text] [Related]
15. Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET. Tinianow JN, Gill HS, Ogasawara A, Flores JE, Vanderbilt AN, Luis E, Vandlen R, Darwish M, Junutula JR, Williams SP, Marik J. Nucl Med Biol; 2010 Apr 01; 37(3):289-97. PubMed ID: 20346868 [Abstract] [Full Text] [Related]
16. PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats. Brouwers A, Verel I, Van Eerd J, Visser G, Steffens M, Oosterwijk E, Corstens F, Oyen W, Van Dongen G, Boerman O. Cancer Biother Radiopharm; 2004 Apr 01; 19(2):155-63. PubMed ID: 15186595 [Abstract] [Full Text] [Related]
17. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody. Rylova SN, Del Pozzo L, Klingeberg C, Tönnesmann R, Illert AL, Meyer PT, Maecke HR, Holland JP. J Nucl Med; 2016 Jan 01; 57(1):96-102. PubMed ID: 26514172 [Abstract] [Full Text] [Related]